CoChat

PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells

Open access
Mannava, S, Omilian, A R, Wawrzyniak, J A, Fink, E E, Zhuang, D, Miecznikowski, J C, Marshall, J R, Soengas, M S, Sears, R C, Morrison, C D, Nikiforov, M A · 2012 · Oncogene
Cited by 42

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Oncoprotein C-MYC is overexpressed in human metastatic melanomas and melanoma-derived cells where it is required for the suppression of oncogene-induced senescence (OIS). The genetic events that maintain high levels of C-MYC in melanoma cells and their role in OIS are unknown. Here we report that C-MYC in cells from several randomly chosen melanoma lines was upregulated at the protein level, and largely because of the increased protein stability. Of all known regulators of C-MYC stability, levels of B56α subunit of the PP2A tumor suppressor complex were substantially suppressed in all human melanoma cells compared with normal melanocytes. Accordingly, immunohistochemical analysis revealed that the lowest and the highest amounts of PP2A-B56α were predominantly detected in metastatic melanoma tissues and in primary melanomas from patients with good clinical outcome, respectively. Importantly, PP2A-B56α overexpression suppressed C-MYC in melanoma cells and induced OIS, whereas depletion of PP2A-B56α in normal human melanocytes upregulated C-MYC protein levels and suppressed BRAFV600E- and, less efficiently, NRASQ61R-induced senescence. Our data reveal a mechanism of C-MYC overexpression in melanoma cells and identify a functional role for PP2A-B56α in OIS of melanocytic cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2011.339

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Distinct Sets of Genetic Alterations in Melanoma

    Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747

  • BRAFE600-associated senescence-like cell cycle arrest of human naevi

    Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 2×

    “One of the best examples of naturally occurring OIS in humans is the nevus, a benign aggregation of non-proliferative melanocytes that often harbor activating mutations in BRAF, NRAS or HRAS genes (Pollock et al., 2003; Michaloglou et al., 2005; Gray-Schopfer et al., 2007).”
    BackgroundSelf-citation
  • High frequency of BRAF mutations in nevi

    Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730 · cited 4×

    “Intriguingly, activating mutations in the same genes have been detected in several types of malignant melanomas but at lower frequencies (Pollock et al., 2003; Curtin et al., 2005; Maldonado et al., 2003), indicating that malignant melanomas that often originate from nevi must have developed…”
    BackgroundInfluential
  • Melanoma biology and new targeted therapy

    Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007) · Nature · doi:10.1038/nature05661 · Cited by 1,371 · cited 2×

    “One of the best examples of naturally occurring OIS in humans is the nevus, a benign aggregation of non-proliferative melanocytes that often harbor activating mutations in BRAF, NRAS or HRAS genes (Pollock et al., 2003; Michaloglou et al., 2005; Gray-Schopfer et al., 2007).”
    Background
  • CIP2A inhibits PP2A in human malignancies

    Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677 · cited 2×

    “Other proteins regulating C-MYC stability include: CIP2A, a C-MYC-interacting protein that specifically inhibits PP2A activity against C-MYC (Junttila et al., 2007); USP28, a deubiquitinating enzymes that antagonizes FBW7 and promotes C-MYC stability (Popov et al., 2007) and TRUSS, a receptor for…”
    BackgroundSelf-citation
  • Determinants of BRAF Mutations in Primary Melanomas

    Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., Ono, T., Albertson, D. G., Pinkel, D., & Bastian, B. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg123 · Cited by 664 · cited 2×

    “…mutations in the same genes have been detected in several types of malignant melanomas but at lower frequencies (Pollock et al., 2003; Curtin et al., 2005; Maldonado et al., 2003), indicating that malignant melanomas that often originate from nevi must have developed mechanisms that circumvent OIS.”
    Background
  • Parameters behind “Nonparametric” Statistics: Kendall's tau, Somers’ D and Median Differences

    Newson, R. (2002) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0200200103 · Cited by 394

  • Tumor suppressors and oncogenes in cellular senescence

    Bringold, F., & Serrano, M. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00083-8 · Cited by 379

  • Oncogene-Induced Cell Senescence — Halting on the Road to Cancer

    Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371

  • Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway

    Denoyelle, C., Abou-Rjaily, G., Bezrookove, V., Verhaegen, M., Johnson, T. M., Fullen, D. R., Pointer, J. N., Gruber, S. B., Su, L. D., Nikiforov, M. A., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1471 · Cited by 349 · cited 10×

    “Lentiviral constructs and infection Lentiviral infection protocols and vectors containing control shRNA, C-MYC shRNA, cDNAs of BRAFV600E, NRASQ61R and HRASG12V were described previously (Denoyelle et al., 2006; Arnold and Sears, 2006).”
    BackgroundMethodInfluentialSelf-citation

Show all 15 references

Cited by

See all 42

Metadata

Authors
Mannava, S., Omilian, A. R., Wawrzyniak, J. A., Fink, E. E., Zhuang, D., Miecznikowski, J. C., Marshall, J. R., Soengas, M. S., Sears, R. C., Morrison, C. D., & Nikiforov, M. A.
Venue
Oncogene
Published
2011-08-08
Volume
31
Issue
12
Pages
1484-1492
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W1971345156
Cited by
42
References
15
FWCI
2.31
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells. https://app.cochat.ai/papers/10.1038/onc.2011.339
The paper
Mannava, S., Omilian, A. R., Wawrzyniak, J. A., Fink, E. E., Zhuang, D., Miecznikowski, J. C., Marshall, J. R., Soengas, M. S., Sears, R. C., Morrison, C. D., & Nikiforov, M. A. (2012). PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene. https://doi.org/10.1038/onc.2011.339

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.